Skip to content
Screener

The Cooper Companies, Inc. COO Fertility — Net Sales

Other product segments

Toric and multifocal
$364.9M+11.1%
Sphere, other
$358.6M+5.1%
Office and surgical
$214.2M+4.1%

Similar metrics at other companies

General Mills logo
GISPet — Net Sales
$746.6M+5.8%
POS
POSTNut butters — Net Sales
$92M+295%
POS
POSTPet Food — Net Sales
$318.8M-12.6%
Wabash National logo
WNCNew trailers — Net Sales
$317.05M+1.6%
Amazon logo
AMZNNet product sales — Net Sales
$71.3B+11.5%
Amazon logo
AMZNNet service sales — Net Sales
$110.22B+20.2%

Other financials

Income statement

See full
Revenue$1.1B+7.9%
Gross profit$735.4M+8.3%
Operating income-$31.0M-117%
Net income-$77.9M-189%
EPS (diluted)-$0.40-191%

Balance sheet

See full
Cash & equivalents$139.0M+19.6%
Total debt$3.1B+15.6%
Total equity$8.2B-0.6%
Total assets$12.5B+0.6%

Cash flow

See full
Operating cash flow$182.8M+90.0%
CapEx$86.4M+10.6%
Free cash flow$96.4M+433%

Valuation

See full
Market cap$14.3B+5.2%
Enterprise value$17.22B+7.7%
P/E60.6×+27.3×
P/S3.4×0.0×

Profitability

See full
Gross margin65.5%-1.6pp
Operating margin11.8%-7.2pp
Net margin5.6%-4.8pp
FCF margin13.5%+4.3pp

Returns & leverage

See full
Return on equity2.9%-2.3pp
Debt / equity0.4×+0.1×
Current ratio1.3×-0.8×

Where this comes from

Reported directly by The Cooper Companies, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: The Cooper Companies, Inc.’s 10-Q, filed June 5, 2026.

Filed
Jun 5, 2026, 4:47 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-041305
Periods Ended April 30, / (In millions)Three Months / 2026Three Months / 2025Six Months / 2026Six Months / 2025
Toric and multifocal$364.9$328.4$716.1$647.8
Sphere, other358.6341.2702.5667.9
Total CooperVision net sales$723.5$669.6$1,418.6$1,315.7
CooperSurgical net sales by category:
Office and surgical$214.2$205.8$416.6$404.7
Fertility143.8126.9270.4246.6
Total CooperSurgical net sales358.0332.7687.0651.3
Total net sales$1,081.5$1,002.3$2,105.6$1,967.0

Item 1. Unaudited Financial Statements

FAQ

What is The Cooper Companies, Inc.'s fertility — net sales?
The Cooper Companies, Inc. (COO) reported fertility — net sales of $143.8M in Q1 2026.
How has The Cooper Companies, Inc.'s fertility — net sales changed year-over-year?
The Cooper Companies, Inc.'s fertility — net sales increased by 13.3% year-over-year, from $126.9M to $143.8M.
What is the long-term trend for The Cooper Companies, Inc.'s fertility — net sales?
Over 4 years (2021 to 2025), The Cooper Companies, Inc.'s fertility — net sales has grown at a 13.2% compound annual growth rate (CAGR), from $319.2M to $524.6M.
What does fertility — net sales mean?
This metric represents the total revenue generated from the sale of products and services within the fertility business unit. It reflects the company's market performance in reproductive health, including medical devices and diagnostic solutions used in fertility treatments. This figure is a key indicator of the segment's growth trajectory and its contribution to the overall corporate revenue stream.

Ask your AI about The Cooper Companies, Inc.'s fertility — net sales.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude